Neural Stem Cells Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Neural Stem Cells market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.5% during the forecast period.

    This report presents the market size and development trends by detailing the Neural Stem Cells market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Neural Stem Cells market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Neural Stem Cells industry and will help you to build a panoramic view of the industrial development.

    Neural Stem Cells Market, By Type:

    • Neural Crest Stem Cell(NC-SC)

    • CNS Stem Cells(CNS-SC)

    Neural Stem Cells Market, By Application:

    • Neurodevelopmental

    • Repair damaged nerve tissue

    • Others

    Some of the leading players are as follows:

    • Becton Dickinson.

    • Takara Holdings Inc

    • Corestem Inc, Corning Inc

    • Fibrocell Science Inc

    • Celgene Corporation

    • Cytori Therapeutics

    • Stemedica Cell Technologies Inc

    • Biotime Inc.

    • Cellular Engineering Technologies Inc

    • Brainstorm Cell Therapeutics

    • Cellular Dynamics International

    • Kangstem Biotech Ltd

    • Ge Healthcare

    • Thermo Fisher Vericel Corporation

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Neural Stem Cells Market: Technology Type Analysis

    • 4.1 Neural Stem Cells Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Neural Stem Cells Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Neural Crest Stem Cell(NC-SC)

      • 4.3.2 CNS Stem Cells(CNS-SC)

    5 Neural Stem Cells Market: Product Analysis

    • 5.1 Neural Stem Cells Product Market Share Analysis, 2018 & 2026

    • 5.2 Neural Stem Cells Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Neural Stem Cells Market: Application Analysis

    • 6.1 Neural Stem Cells Application Market Share Analysis, 2018 & 2026

    • 6.2 Neural Stem Cells Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Neurodevelopmental

      • 6.3.2 Repair damaged nerve tissue

      • 6.3.3 Others

    7 Neural Stem Cells Market: Regional Analysis

    • 7.1 Neural Stem Cells Regional Market Share Analysis, 2018 & 2026

    • 7.2 Neural Stem Cells Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Becton Dickinson.

      • 9.1.1 Becton Dickinson. Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Takara Holdings Inc

      • 9.2.1 Takara Holdings Inc Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Corestem Inc, Corning Inc

      • 9.3.1 Corestem Inc, Corning Inc Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Fibrocell Science Inc

      • 9.4.1 Fibrocell Science Inc Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Celgene Corporation

      • 9.5.1 Celgene Corporation Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Cytori Therapeutics

      • 9.6.1 Cytori Therapeutics Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Stemedica Cell Technologies Inc

      • 9.7.1 Stemedica Cell Technologies Inc Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Biotime Inc.

      • 9.8.1 Biotime Inc. Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Cellular Engineering Technologies Inc

      • 9.9.1 Cellular Engineering Technologies Inc Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Brainstorm Cell Therapeutics

      • 9.10.1 Brainstorm Cell Therapeutics Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Cellular Dynamics International

      • 9.11.1 Cellular Dynamics International Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Kangstem Biotech Ltd

      • 9.12.1 Kangstem Biotech Ltd Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Ge Healthcare

      • 9.13.1 Ge Healthcare Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Thermo Fisher Vericel Corporation

      • 9.14.1 Thermo Fisher Vericel Corporation Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

     

    The List of Tables and Figures (Totals 99 Figures and 125 Tables)

    • Figure Neural Crest Stem Cell(NC-SC) Neural Stem Cells market, 2015 - 2026 (USD Million)

    • Figure CNS Stem Cells(CNS-SC) Neural Stem Cells market, 2015 - 2026 (USD Million)

    • Figure Neurodevelopmental market, 2015 - 2026 (USD Million)

    • Figure Repair damaged nerve tissue market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Neural Stem Cells market, by country, 2015 - 2026 (USD Million)

    • Table North America Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table North America Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table North America Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Canada Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Canada Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Europe Neural Stem Cells market, by country, 2015 - 2026 (USD Million)

    • Table Europe Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Europe Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Europe Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Germany Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Germany Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table France Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table France Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Italy Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Italy Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Spain Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Spain Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Neural Stem Cells market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table China Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table China Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Japan Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Japan Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table India Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table India Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Neural Stem Cells market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table MEA Neural Stem Cells market, by country, 2015 - 2026 (USD Million)

    • Table MEA Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table MEA Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table MEA Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Neural Stem Cells market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Neural Stem Cells market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Neural Stem Cells market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Becton Dickinson. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Takara Holdings Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Corestem Inc, Corning Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fibrocell Science Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Celgene Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cytori Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Stemedica Cell Technologies Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biotime Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cellular Engineering Technologies Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Brainstorm Cell Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cellular Dynamics International Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Kangstem Biotech Ltd Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ge Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Thermo Fisher Vericel Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.